Pes Plano ValgusNCT06763523
Arthroereisis With Corrective Osteotomy Versus Arthroereisis Alone in Management of Symptomatic Flexible Pes Planovalgus in Adolescents
A study testing arthroereisis of the subtalar joint in people with Pes Plano Valgus, run by Sohag University at 1 site in Egypt.
Trial summary
Arthroereisis ,corrective osteotomies, flexible pes planovalgus, adolescents Read more about this study
- Who is it for?
- Ages 10 to 17 yearsHealthy volunteers can take part
- Conditions the study is for
- Pes Plano Valgus
- What is being tested?
- arthroereisis of the subtalar joint
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 19 Jan 2025to 20 Jan 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 17 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- cases complaining of flexible pes planovalgus non responsive for conservative treatment and cases with generalized ligamentous laxity
Who cannot join
- neurological disorders and rigid peaplanovalgus
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Sohag university
Sohag
Marwan S Mohamed, lecturer, 01063196414, marwanshams10@gmail.com
About this study
Arthroereisis ,corrective osteotomies, flexible pes planovalgus, adolescents
- Conditions
- Pes Plano Valgus
- Being tested
- arthroereisis of the subtalar joint
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
arthroereisis of the subtalar jointProcedure or surgery
arthroereisis alone versus arthroereisis combined with corrective osteotomies
| Study group | Role | What they receive |
|---|---|---|
| Group B | Active comparator | arthroereisis without corrective osteotomies Receives: Procedure: arthroereisis of the subtalar joint |
| Group A | Active comparator | arthroereisis with corrective osteotomies Receives: Procedure: arthroereisis of the subtalar joint |
What is being measured
The primary outcome is the main question the study is designed to answer.
AOFAS score
American Orthopaedic Foot \& Ankle Society
Measured: 2 years from the start of the study
Secondary outcomes (1)
VAS score
visual analog score
Measured: 2 years from the start of the study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2025
- Study start19 Jan 2025 (estimated)
- Primary completion20 Jan 2025 (estimated)
- Study completion20 Jan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pes Plano ValgusStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Mohy Eldien Abdelrahman, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06763523
- Sponsor's protocol ID
- Soh-24-12---1MD
- Status last verified
- Jan 2025
- First submitted
- 23 Dec 2024
- Last updated
- 8 Jan 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Arthroereisis With Corrective Osteotomy Versus Arthroereisis Alone in Management of Symptomatic Flexible Pes Planovalgus in Adolescents
- ClinicalTrials.gov ID
- NCT06763523
- Acronym / sponsor ID
- Soh-24-12---1MD
- Conditions
- Pes Plano Valgus
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 19 Jan 2025 (estimated)
- Primary completion
- 20 Jan 2025 (estimated)
- Study completion
- 20 Jan 2026 (estimated)
- First posted
- 8 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Arthroereisis ,corrective osteotomies, flexible pes planovalgus, adolescents
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group B | Active comparator | Procedure: arthroereisis of the subtalar jointarthroereisis without corrective osteotomies |
| Group A | Active comparator | Procedure: arthroereisis of the subtalar jointarthroereisis with corrective osteotomies |
Who may qualify
- Ages
- 10 to 17 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- cases complaining of flexible pes planovalgus non responsive for conservative treatment and cases with generalized ligamentous laxity
Key exclusion criteria (1 listed)
- neurological disorders and rigid peaplanovalgus
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| arthroereisis of the subtalar jointarthroereisis alone versus arthroereisis combined with corrective osteotomies | Procedure or surgery | Group A, Group B |
Primary outcome
AOFAS score
Time frame: 2 years from the start of the study
American Orthopaedic Foot \& Ankle Society
1 secondary outcome
VAS score
Time frame: 2 years from the start of the study
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2025.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing arthroereisis of the subtalar joint in people with Pes Plano Valgus, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 8 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Ahmed Mohieldien Abdelrahman, specialist (01060480320, ahmed.elsayed2@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
AOFAS score (time frame: 2 years from the start of the study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2025; AzTrials last refreshed its copy on 7 Nov 2026.